New ICD-10 PCS Codes in 2025

412 codes were added to the 2025 ICD-10-PCS code set, effective October 1, 2024.

0NPW45Z - Removal Facial Bone to No Qualifier with External Fixation Device, Percutaneous Endoscopic Approach
0NPWX5Z - Removal Facial Bone to No Qualifier with External Fixation Device, External Approach
0NWB05Z - Revision Nasal Bone to No Qualifier with External Fixation Device, Open Approach
0NWB35Z - Revision Nasal Bone to No Qualifier with External Fixation Device, Percutaneous Approach
0NWB45Z - Revision Nasal Bone to No Qualifier with External Fixation Device, Percutaneous Endoscopic Approach
0NWBX5Z - Revision Nasal Bone to No Qualifier with External Fixation Device, External Approach
0NWW05Z - Revision Facial Bone to No Qualifier with External Fixation Device, Open Approach
0NWW35Z - Revision Facial Bone to No Qualifier with External Fixation Device, Percutaneous Approach
0NWW45Z - Revision Facial Bone to No Qualifier with External Fixation Device, Percutaneous Endoscopic Approach
0NWWX5Z - Revision Facial Bone to No Qualifier with External Fixation Device, External Approach
0TT04ZG - Resection Kidney, Right to Hand-Assisted with No Device, Percutaneous Endoscopic Approach
0TT14ZG - Resection Kidney, Left to Hand-Assisted with No Device, Percutaneous Endoscopic Approach
0TT24ZG - Resection Kidneys, Bilateral to Hand-Assisted with No Device, Percutaneous Endoscopic Approach
3E0L317 - Introduction Pleural Cavity to Other Thrombolytic with Thrombolytic, Percutaneous Approach
5A05A0L - Assistance Circulatory to Peripheral Veno-venous with Filtration, Intraoperative Approach
8E023FZ - Other Procedures Circulatory System to No Qualifier with Fiber Optic 3D Guided Procedure, Percutaneous Approach
X05133A - Destruction Renal Sympathetic Nerve(s) to New Technology Group 10 with Radiofrequency Ablation, Percutaneous Approach
X27P3TA - Dilation Anterior Tibial Artery, Right to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach
X27Q3TA - Dilation Anterior Tibial Artery, Left to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach
X27R3TA - Dilation Posterior Tibial Artery, Right to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach
X27S3TA - Dilation Posterior Tibial Artery, Left to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach
X27T3TA - Dilation Peroneal Artery, Right to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach
X27U3TA - Dilation Peroneal Artery, Left to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach
X28F3VA - Division Aortic Valve to New Technology Group 10 with Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach
X2R50WA - Replacement Upper Extremity Artery, Right to New Technology Group 10 with Bioengineered Human Acellular Vessel, Open Approach
X2R60WA - Replacement Upper Extremity Artery, Left to New Technology Group 10 with Bioengineered Human Acellular Vessel, Open Approach
X2R70WA - Replacement Lower Extremity Artery, Right to New Technology Group 10 with Bioengineered Human Acellular Vessel, Open Approach
X2R80WA - Replacement Lower Extremity Artery, Left to New Technology Group 10 with Bioengineered Human Acellular Vessel, Open Approach
X2RJ3RA - Replacement Tricuspid Valve to New Technology Group 10 with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach
X2VE3SA - Restriction Descending Thoracic Aorta and Abdominal Aorta to New Technology Group 10 with Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries, Percutaneous Approach
XHR0XGA - Replacement Skin, Head and Neck to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach
XHR1XGA - Replacement Skin, Chest to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach
XHR2XGA - Replacement Skin, Abdomen to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach
XHR3XGA - Replacement Skin, Back to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach
XHR4XGA - Replacement Skin, Right Upper Extremity to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach
XHR5XGA - Replacement Skin, Left Upper Extremity to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach
XHR6XGA - Replacement Skin, Right Lower Extremity to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach
XHR7XGA - Replacement Skin, Left Lower Extremity to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach
XRGA0EA - Fusion Thoracolumbar Vertebral Joint to New Technology Group 10 with Facet Joint Fusion Device, Paired Titanium Cages, Open Approach
XRGB0EA - Fusion Lumbar Vertebral Joint to New Technology Group 10 with Facet Joint Fusion Device, Paired Titanium Cages, Open Approach
XRGC0EA - Fusion Lumbar Vertebral Joints, 2 or more to New Technology Group 10 with Facet Joint Fusion Device, Paired Titanium Cages, Open Approach
XRGD0EA - Fusion Lumbosacral Joint to New Technology Group 10 with Facet Joint Fusion Device, Paired Titanium Cages, Open Approach
XRGJ0CA - Fusion Ankle Joint, Right to New Technology Group 10 with Internal Fixation Device, Gyroid-Sheet Lattice Design, Open Approach
XRGK0CA - Fusion Ankle Joint, Left to New Technology Group 10 with Internal Fixation Device, Gyroid-Sheet Lattice Design, Open Approach
XRGL0CA - Fusion Tarsal Joint, Right to New Technology Group 10 with Internal Fixation Device, Gyroid-Sheet Lattice Design, Open Approach
XRGM0CA - Fusion Tarsal Joint, Left to New Technology Group 10 with Internal Fixation Device, Gyroid-Sheet Lattice Design, Open Approach
XRH60FA - Insertion Thoracic Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach
XRH63FA - Insertion Thoracic Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach
XRH64FA - Insertion Thoracic Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach
XRH70FA - Insertion Thoracic Vertebral Joints, 2 to 7 to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach
XRH73FA - Insertion Thoracic Vertebral Joints, 2 to 7 to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach
XRH74FA - Insertion Thoracic Vertebral Joints, 2 to 7 to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach
XRH80FA - Insertion Thoracic Vertebral Joints, 8 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach
XRH83FA - Insertion Thoracic Vertebral Joints, 8 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach
XRH84FA - Insertion Thoracic Vertebral Joints, 8 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach
XRHA0FA - Insertion Thoracolumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach
XRHA3FA - Insertion Thoracolumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach
XRHA4FA - Insertion Thoracolumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach
XRHB0FA - Insertion Lumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach
XRHB3FA - Insertion Lumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach
XRHB4FA - Insertion Lumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach
XRHC0FA - Insertion Lumbar Vertebral Joints, 2 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach
XRHC3FA - Insertion Lumbar Vertebral Joints, 2 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach
XRHC4FA - Insertion Lumbar Vertebral Joints, 2 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach
XRHD0FA - Insertion Lumbosacral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach
XRHD3FA - Insertion Lumbosacral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach
XRHD4FA - Insertion Lumbosacral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach
XW01329 - Introduction Subcutaneous Tissue to New Technology Group 9 with Talquetamab Antineoplastic, Percutaneous Approach
XW0136A - Introduction Subcutaneous Tissue to New Technology Group 10 with Dasiglucagon, Percutaneous Approach
XW0333A - Introduction Peripheral Vein to New Technology Group 10 with Bentracimab, Ticagrelor Reversal Agent, Percutaneous Approach
XW0334A - Introduction Peripheral Vein to New Technology Group 10 with Cefepime-taniborbactam Anti-infective, Percutaneous Approach
XW0335A - Introduction Peripheral Vein to New Technology Group 10 with Ceftobiprole Medocaril Anti-infective, Percutaneous Approach
XW0338A - Introduction Peripheral Vein to New Technology Group 10 with Obecabtagene Autoleucel, Percutaneous Approach
XW0339A - Introduction Peripheral Vein to New Technology Group 10 with Odronextamab Antineoplastic, Percutaneous Approach
XW033BA - Introduction Peripheral Vein to New Technology Group 10 with Orca-T Allogeneic T-cell Immunotherapy, Percutaneous Approach
XW033CA - Introduction Peripheral Vein to New Technology Group 10 with Zanidatamab Antineoplastic, Percutaneous Approach
XW033DA - Introduction Peripheral Vein to New Technology Group 10 with Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension, Percutaneous Approach
XW033FA - Introduction Peripheral Vein to New Technology Group 10 with Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy, Percutaneous Approach
XW0433A - Introduction Central Vein to New Technology Group 10 with Bentracimab, Ticagrelor Reversal Agent, Percutaneous Approach
XW0434A - Introduction Central Vein to New Technology Group 10 with Cefepime-taniborbactam Anti-infective, Percutaneous Approach
XW0435A - Introduction Central Vein to New Technology Group 10 with Ceftobiprole Medocaril Anti-infective, Percutaneous Approach
XW0438A - Introduction Central Vein to New Technology Group 10 with Obecabtagene Autoleucel, Percutaneous Approach
XW0439A - Introduction Central Vein to New Technology Group 10 with Odronextamab Antineoplastic, Percutaneous Approach
XW043BA - Introduction Central Vein to New Technology Group 10 with Orca-T Allogeneic T-cell Immunotherapy, Percutaneous Approach
XW043CA - Introduction Central Vein to New Technology Group 10 with Zanidatamab Antineoplastic, Percutaneous Approach
XW043FA - Introduction Central Vein to New Technology Group 10 with Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy, Percutaneous Approach
XW0J3HA - Introduction Coronary Artery, One Artery to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, One Balloon, Percutaneous Approach
XW0J3JA - Introduction Coronary Artery, One Artery to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Two Balloons, Percutaneous Approach
XW0J3KA - Introduction Coronary Artery, One Artery to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Three Balloons, Percutaneous Approach
XW0J3LA - Introduction Coronary Artery, One Artery to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Four or More Balloons, Percutaneous Approach
XW0K3HA - Introduction Coronary Artery, Two Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, One Balloon, Percutaneous Approach
XW0K3JA - Introduction Coronary Artery, Two Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Two Balloons, Percutaneous Approach
XW0K3KA - Introduction Coronary Artery, Two Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Three Balloons, Percutaneous Approach
XW0K3LA - Introduction Coronary Artery, Two Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Four or More Balloons, Percutaneous Approach
XW0L3HA - Introduction Coronary Artery, Three Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, One Balloon, Percutaneous Approach
XW0L3JA - Introduction Coronary Artery, Three Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Two Balloons, Percutaneous Approach
XW0L3KA - Introduction Coronary Artery, Three Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Three Balloons, Percutaneous Approach
XW0L3LA - Introduction Coronary Artery, Three Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Four or More Balloons, Percutaneous Approach
XW0M3HA - Introduction Coronary Artery, Four or More Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, One Balloon, Percutaneous Approach
XW0M3JA - Introduction Coronary Artery, Four or More Arteries to New Technology Group 10 with Paclitaxel-Coated Balloon Technology, Two Balloons, Percutaneous Approach